Document ID: chunk:federal_register_of_legislation:F2022C00927:clause:1_1:p3
Version: federal_register_of_legislation:F2022C00927
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 3/3)
Character Range: 20975–22833

= repealed
gaz = gazette                                   rs = repealed and substituted
LA = Legislation Act 2003                       s = section(s)/subsection(s)
LIA = Legislative Instruments Act 2003          Sch = Schedule(s)
(md) = misdescribed amendment can be given      Sdiv = Subdivision(s)
    effect                                      SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
    cannot be given effect                      Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
                                                    commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                     Registration     Commencement       Application, saving and transitional provisions
Statement of Principles concerning conjunctivitis (Balance of Probabilities) (No. 77 of 2020)            3 November 2020  30 November 2020

                                                                                                         F2020L01397
Amendment Statement of Principles concerning conjunctivitis (Balance of Probabilities) (No. 91 of 2022)  29 August 2022   19 September 2022

                                                                                                         F2022L01131

Endnote 4—Amendment history

Provision affected                                                   How affected
Section 2……………….                                                     rep LA s 48D
Section 4……………….                                                     rep LA s 48C
Subsection 9(5A)………                                                  ad No. 91 of 2022